What is the subscription status of Q-Line Biotech IPO?

As of May 25, 2026, the Q-Line Biotech IPO subscription stands at 102.49× overall, QIB 123.94×, NII 146.33×, Retail N/A.

Q-Line Biotech IPO Subscription History

Q: What is the allotment probability for Q-Line Biotech IPO?

Based on current retail subscription of data unavailable, the allotment probability for Q-Line Biotech IPO retail investors is estimated as Very Low. Only 1 lot likely via lottery if selected.

Q: How can I check Q-Line Biotech IPO allotment status?

You can check your Q-Line Biotech IPO allotment status on the registrar&#039;s website (Purva Sharegistry (India) Private Limited) using your PAN number, application number, or DP/Client ID. Alternatively, check through your demat account portal or BSE/NSE websites. Allotment basis date: May 26, 2026.

Q: When will Q-Line Biotech IPO be listed?

Q-Line Biotech IPO listing date is May 29, 2026, on NSE SME platform. Shares will be credited to allottee demat accounts 1 day before listing.

NSE SME

Subscription Status · May 21 – May 25, 2026 · ₹326–349

Full IPO Details

The Q-Line Biotech IPO subscription has recorded exceptional investor demand with an overall subscription of 102.49× as of May 25, 2026, indicating that investors applied for 102.49 times the number of shares on offer. All investor categories (institutional, HNI, and retail) have participated actively, making this one of the closely watched IPO openings.

QIB (Qualified Institutional Buyers) subscribed 123.94×, heavyweight participation from mutual funds, foreign institutional investors (FIIs), and domestic banks. Strong QIB demand is widely regarded as one of the most reliable indicators of a successful listing.
HNI / NII category. Big NII (bids above ₹10 lakh) subscribed 178.82× and Small NII (below ₹10 lakh) subscribed 81.35×. High-net-worth investors are aggressively leveraging borrowed funds, signalling strong listing-gain expectations.

QIB

123.94×

Qualified Institutional Buyers

NII

146.33×

Non-Institutional Investors

bNII

178.82×

Bids above ₹10L

sNII

81.35×

Bids below ₹10L

Individual

71.44×

Individual Investors

Total

102.49×

Massively Oversubscribed

Live Subscription Data

Last updated: May 25, 2026, 6:21 PM IST

Overall

102.49×

Category	Shares Offered	Shares Bid For	Times Subscribed	Applications
QIB Qualified Institutional Buyers	1,188,000	147,237,200	123.94×	197
NII Non-Institutional Investors	891,600	130,466,800	146.33×	49,781
bNII Bids above ₹10L	594,400	106,289,200	178.82×	31,162
sNII Bids below ₹10L	297,200	24,177,600	81.35×	18,619
Individual Individual Investors	2,079,200	148,541,600	71.44×	185,677
Total	4,158,800	426,245,600	102.49×	285,436

Massively Oversubscribed — 102.49× overall Allotment probability may be lower due to high demand

Day-wise Subscription Trend

How subscription built up across investor categories over time

Day-wise Subscription History

Snapshot of each day's bidding activity

Thu, May 21, 2026

4.11× 13,154 apps

Category	Offered	Bid For	Times	Applications
QIB	1,188,000	4,929,600	4.15×	7
NII	891,600	4,668,800	5.24×	1,887
bNII	594,400	3,472,400	5.84×	935
sNII	297,200	1,196,400	4.03×	952
Individual Investors	2,079,200	7,498,400	3.61×	9,373
Total	4,158,800	17,096,800	4.11×	13,154

Fri, May 22, 2026

9.86× 37,007 apps

Category	Offered	Bid For	Times	Applications
QIB	1,188,000	6,164,400	5.19×	27
NII	891,600	14,226,800	15.96×	5,601
bNII	594,400	10,987,600	18.49×	3,079
sNII	297,200	3,239,200	10.90×	2,522
Individual Investors	2,079,200	20,622,400	9.92×	25,778
Total	4,158,800	41,013,600	9.86×	37,007

Mon, May 25, 2026

102.49× 285,436 apps

Category	Offered	Bid For	Times	Applications
QIB	1,188,000	147,237,200	123.94×	197
NII	891,600	130,466,800	146.33×	49,781
bNII	594,400	106,289,200	178.82×	31,162
sNII	297,200	24,177,600	81.35×	18,619
Individual Investors	2,079,200	148,541,600	71.44×	185,677
Total	4,158,800	426,245,600	102.49×	285,436

Frequently Asked Questions

What is the current subscription status of Q-Line Biotech IPO?

As of May 25, 2026, the Q-Line Biotech IPO has been subscribed 102.49 times overall. The IPO is fully subscribed with strong investor demand indicating extremely high interest. A total of 285,436 applications received across all categories.

When was the Q-Line Biotech IPO subscription window open?

The Q-Line Biotech IPO subscription window was open from May 21, 2026 to May 25, 2026. Investors could apply through their demat account or ASBA facility.

What is the price band and minimum investment for Q-Line Biotech IPO?

The Q-Line Biotech IPO has a price band of ₹326 to ₹349 per share, with a lot size of 400 shares. Minimum retail investment: ₹130,400 (lower band) or ₹139,600 (upper band).

What is the QIB subscription for Q-Line Biotech IPO?

The QIB category has been subscribed 123.94 times. QIBs were offered 1,188,000 shares. Strong QIB subscription indicates high institutional confidence.

What is the NII subscription for Q-Line Biotech IPO?

Overall NII: 146.33×. bNII (>₹10L): 178.82×, sNII (<₹10L): 81.35×. NII includes HNIs and corporate entities investing above ₹2 lakh.

How can I check my Q-Line Biotech IPO allotment status?

Basis of allotment is on May 26, 2026. Check via the registrar's website, Purva Sharegistry (India) Private Limited using your PAN number, application number, or DP/Client ID. You can also check on BSE/NSE websites or through your broker's app.

When will Q-Line Biotech IPO be listed?

Q-Line Biotech IPO is expected to list on May 29, 2026. Shares will list on NSE SME platform. Allotted shares are credited to your demat account 1 business day before listing.

What does 102.49× subscription mean for Q-Line Biotech IPO?

A subscription multiple of 102.49× means investors have bid for 102.49 times the total shares available. Since the IPO is oversubscribed, not every applicant will receive shares, allotment happens via lottery (for retail) or proportionately (for other categories). Higher multiples generally reduce allotment probability.

What is the allotment probability for Q-Line Biotech IPO retail investors?

Based on the current retail subscription of data pending, the estimated allotment probability for retail investors is Very Low. Only 1 lot likely via lottery if selected. If final subscription stays below 1×, all applicants are likely to get full allotment.

How to apply for Q-Line Biotech IPO?

You can apply for Q-Line Biotech IPO through: (1) ASBA (Application Supported by Blocked Amount) via your bank's net banking or mobile app, (2) UPI-based application through your broker's app (Zerodha, Groww, Angel One, etc.), or (3) directly via your demat account. The amount is blocked in your account and deducted only upon allotment. Applications were accepted from May 21 to May 25, 2026.

What is the grey market premium (GMP) for Q-Line Biotech IPO?

The grey market premium (GMP) reflects unofficial pre-listing trading sentiment. For the latest Q-Line Biotech IPO GMP data, check the IPORise GMP page. Note: GMP is unofficial, speculative, and not a guaranteed indicator of listing price. Use it only as a sentiment signal alongside official subscription data.

New to reading subscription numbers? Read our guide on IPO subscription explained.